Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for SOPHiA GENETICS SA (SOPH : NSDQ)

• Company Description    SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON. Number of Employees: 423

• Price / Volume Information    Yesterday's Closing Price: $4.67 Daily Weekly Monthly 20 Day Moving Average: 48,881 shares Shares Outstanding: 67.58 (millions) Market Capitalization: $315.60 (millions) Beta: 1.11 52 Week High: $5.30 52 Week Low: $2.58 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -6.97% -6.81% 12 Week 2.41% 0.76% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL LA PIECE CH-1180 - ROLLE,V8 00000 CHE ph: 41-21-694-1060 fax: - None http://www.sophiagenetics.com

• General Corporate Information    Officers Jurgi Camblong - Chief Executive Officer Troy Cox - Chairman Ross Muken - President George Cardoza - Chief Financial Officer Tomer Berkovitz - Director Peer Information SOPHiA GENETICS SA (HLIS) SOPHiA GENETICS SA (AZTA) SOPHiA GENETICS SA (APYI) SOPHiA GENETICS SA (RNVA) SOPHiA GENETICS SA (HMSY) SOPHiA GENETICS SA (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: H82027105 SIC: 7374 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/03/26 Share - Related Items Shares Outstanding: 67.58 Most Recent Split Date: (:1) Beta: 1.11 Market Capitalization: $315.60 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/03/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 5.20 Price/Cash Flow: - Price / Sales: 4.31 EPS Growth vs. Year Ago Period: -7.14% vs. Previous Quarter: -190.91% Sales Growth vs. Year Ago Period: 22.77% vs. Previous Quarter: 6.22% ROE 12/31/25 - - 09/30/25 - -37.75 06/30/25 - -30.69 ROA 12/31/25 - - 09/30/25 - -18.75 06/30/25 - -17.39 Current Ratio 12/31/25 - - 09/30/25 - 2.80 06/30/25 - 3.39 Quick Ratio 12/31/25 - - 09/30/25 - 2.62 06/30/25 - 3.21 Operating Margin 12/31/25 - - 09/30/25 - -41.13 06/30/25 - -40.99 Net Margin 12/31/25 - - 09/30/25 - -41.13 06/30/25 - -40.99 Pre-Tax Margin 12/31/25 - - 09/30/25 - -98.85 06/30/25 - -102.43 Book Value 12/31/25 - - 09/30/25 - 0.90 06/30/25 - 1.13 Inventory Turnover 12/31/25 - - 09/30/25 - 4.00 06/30/25 - 3.80 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.78 06/30/25 - 0.62 Debt-to-Capital 12/31/25 - - 09/30/25 - 43.95 06/30/25 - 38.23

Powered by Zacks Investment Research ©